GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hugel Inc (XKRX:145020) » Definitions » Stock Based Compensation

Hugel (XKRX:145020) Stock Based Compensation : ₩3,528 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Hugel Stock Based Compensation?

Hugel's Stock Based Compensation for the three months ended in Mar. 2024 was ₩1,061 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 was ₩3,528 Mil.


Hugel Stock Based Compensation Historical Data

The historical data trend for Hugel's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hugel Stock Based Compensation Chart

Hugel Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 766.51 720.20 1,549.49 1,655.49

Hugel Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -811.08 1,488.08 409.49 569.00 1,061.05

Hugel Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩3,528 Mil.


Hugel Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Hugel's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Hugel (XKRX:145020) Business Description

Traded in Other Exchanges
N/A
Address
61-20, Sinbuk-ro, Sinbuk-eup, Chuncheon, Gangwon, KOR, 24206
Hugel Inc is a biopharmaceutical company. It is in the business of manufacturing of biopharmaceuticals. The company's primary products are Botulinum toxin, Hyaluronic acid filler, and Cosmetics. It develops and promotes its products under the brand name of Wellage. The firm has manufacturing facilities in Shinbuk and Geodu.

Hugel (XKRX:145020) Headlines

No Headlines